Cellectis and Genomic Vision Receive €10M for HIV/Herpes
By James Etheridge
Wednesday, November 5, 2008
BioWorld International Correspondent
PARIS - Two French biotech firms, Cellectis SA and Genomic Vision SA, have launched a joint project for the development of a revolutionary treatment for HIV and herpes.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.